MY178484A - A method for controling proteolytic degradation of recombinant proteins - Google Patents
A method for controling proteolytic degradation of recombinant proteinsInfo
- Publication number
- MY178484A MY178484A MYUI2010006296A MYUI2010006296A MY178484A MY 178484 A MY178484 A MY 178484A MY UI2010006296 A MYUI2010006296 A MY UI2010006296A MY UI2010006296 A MYUI2010006296 A MY UI2010006296A MY 178484 A MY178484 A MY 178484A
- Authority
- MY
- Malaysia
- Prior art keywords
- controling
- recombinant proteins
- proteolytic degradation
- recombinant
- inhibiting
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 230000017854 proteolysis Effects 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000526636 Nipah henipavirus Species 0.000 abstract 1
- 101710141454 Nucleoprotein Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6818—Sequencing of polypeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present innovation provides a method to enhance the recovery of recombinant N protein of Nipah virus produced in Escherichia coli, in which by identifying and inhibiting the specific proteases in the cell lysate are achieved by an integrated use of a bioinformatics tool and a protease inhibition experimental setup.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MY2009/000105 WO2011014051A1 (en) | 2009-07-30 | 2009-07-30 | A method for controlling proteolytic degradation of recombinant proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY178484A true MY178484A (en) | 2020-10-14 |
Family
ID=41351461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYUI2010006296A MY178484A (en) | 2009-07-30 | 2009-07-30 | A method for controling proteolytic degradation of recombinant proteins |
Country Status (2)
| Country | Link |
|---|---|
| MY (1) | MY178484A (en) |
| WO (1) | WO2011014051A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011056060A2 (en) * | 2009-11-06 | 2011-05-12 | Universiti Putra Malaysia | Recombinant matrix protein of nipah virus |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8232240B2 (en) * | 2005-02-23 | 2012-07-31 | The Brigham And Women's Hospital, Inc. | Inhibitors of enveloped virus infectivity |
| EP1795606A1 (en) * | 2005-08-11 | 2007-06-13 | DIGILAB BioVisioN GmbH | Method for screening for proteases and their substrates |
-
2009
- 2009-07-30 MY MYUI2010006296A patent/MY178484A/en unknown
- 2009-07-30 WO PCT/MY2009/000105 patent/WO2011014051A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011014051A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201905619T4 (en) | Peptide carrier fusion proteins as allergy vaccines. | |
| MY169472A (en) | Refolding of recombinant proteins | |
| NZ703148A (en) | Modified factor x polypeptides and uses thereof | |
| AU2012257942A8 (en) | Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same | |
| CL2012003291A1 (en) | Method for reducing the amount of a serine protease or a serine protease zymogen in a plasma-derived protein composition of interest; method for preparing a composition of factor h with a reduced amount of a serine protease or a zymogen of serine protease; method for preparing composition of an inter-alpha-trypsin inhibitor. | |
| MX346700B (en) | Method for improving the yield of a polypeptide. | |
| WO2009100260A3 (en) | Compositions and methods comprising basic amino acid peptides and proteases | |
| EA200801531A1 (en) | METHODS OF REGULATION OF MANNOSE CONTENT IN RECOMBINANT PROTEINS | |
| EA201171494A1 (en) | MIMETIC PROTEINS SMAC | |
| MX391266B (en) | HPPD VARIANTS AND METHODS OF USE. | |
| EA201001881A1 (en) | PROLINESCY PROTEZA FROM PENICILLIUM CHRYSOGENUM | |
| CY1118856T1 (en) | Vaccine PCSK9 | |
| AR113492A2 (en) | RECOMBINANT FURIN FREE OF SUBSTANTIALLY ANIMAL PROTEINS AND METHODS TO PRODUCE IT | |
| MX2012013807A (en) | Fusion protein having factor vii activity. | |
| EA201290541A1 (en) | MODIFIED BULL SOMATOTROPINE POLYPEPTIDES AND THEIR APPLICATION | |
| WO2010014922A3 (en) | Protein purification tags and uses thereof | |
| EA201390955A1 (en) | ROBO1-FC fusion protein for use in the treatment of hepatocarcinoma | |
| MX2011011045A (en) | Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities. | |
| NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
| IN2012DN03358A (en) | ||
| MY153917A (en) | Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof | |
| WO2019103512A3 (en) | Novel peptide for enhancing expression efficiency of target protein, and fusion protein comprising same | |
| MX2013008103A (en) | Purification of cell culture derived alpha1 protease inhibitor. | |
| WO2010108182A3 (en) | Production of recombinant proteins in ciliates and uses thereof | |
| MY178484A (en) | A method for controling proteolytic degradation of recombinant proteins |